Search results
Santa Ana Bio secures $168m for inflammatory disease treatments
Pharmaceutical Technology via Yahoo Finance· 4 hours agoThe Series B round, amounting to $125m, was led by GV and saw participation from both existing and...
GSK and Ochre Bio link to explore liver disease drivers
Pharmaceutical Technology via Yahoo Finance· 1 day agoGSK will gain access to cellular and perfused human organ platforms and the computational biology of...
'This also works for Ring': Man says Alibaba dashcam company allowed him remote access to live video...
The Daily Dot· 4 hours agoAn owner of an Alibaba dashcam posted a TikTok after finding out he had access to other customers’...
BIO-key International, Inc. (NASDAQ:BKYI) Short Interest Down 37.1% in May
ETF DAILY NEWS· 1 day agoBIO-key International, Inc. (NASDAQ:BKYI – Get Free Report) was the recipient of a significant decrease in short interest in May. As of May 31st, there was short interest ...
Annovis Bio shareholders approve board and plan amendment By Investing.com
Investing.com· 1 day agoAnnovis Bio, Inc. (NYSE:ANVS), a pharmaceutical company specializing in drug development, announced...
Poop has been an easy target for microbiome research, but voyages into the small intestine shed new...
The Conversation via Yahoo News· 2 hours agoThis article is republished from The Conversation, a nonprofit, independent news organization...
Annovis Bio (NYSE: ANVS) Announces Results of Recent Alzheimer's Study
Digital Journal· 2 days agoAnnovis Bio is headquartered in Malvern, Pennsylvania, and is dedicated to addressing neurodegeneration in diseases such as AD...sectors. It is one of 60+ brands within the ...
'Shame': Ex-GOP lawmaker tears into Mitch McConnell for prostrating himself to Trump
The Raw Story· 14 hours agoFormer Rep. Liz Cheney (R-WY) shredded Senate Minority Leader Mitch McConnell (R-KY) in a post on X...
Tevogen secures $50 million to boost R&D and IP assets By Investing.com
Investing.com· 3 days agoThe financing consists of a $36 million line of credit and a potential $14 million private...
East Bay startup scores $125 million to target one of biotech's hottest areas - San Francisco...
The Business Journals· 18 hours agoAn Alameda biotech startup landed a $125 million round to target a range autoimmune and inflammatory...